OptimizeRx (OPRX) Net Cash Flow (2010 - 2026)

OptimizeRx has disclosed Net Cash Flow across 17 years of filings, most recently posting $3.9 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 32533.33% year-over-year to $3.9 million; the TTM figure through Jun 2026 stood at $7.5 million (up 361.25% YoY), while the FY2025 annual figure was $10.0 million, up 2215.47% from the prior year.
• Net Cash Flow came in at $3.9 million for Q2 2026 at OptimizeRx, up from -$3.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $4.3 million in Q1 2022 to a low of -$46.1 million in Q3 2022.
• Average Net Cash Flow over 5 years is -$3.4 million, with a median of $63500.0 recorded in 2023.
• Year-over-year, Net Cash Flow sank 6068.58% in 2022 and soared 32533.33% in 2026.
• Over 5 years, Net Cash Flow stood at -$23.1 million in 2022, then jumped by 117.0% to $3.9 million in 2023, then slumped by 169.87% to -$2.7 million in 2024, then jumped by 240.06% to $3.8 million in 2025, then advanced by 1.82% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $3.9 million in Q2 2026, -$3.2 million in Q1 2026, and $3.8 million in Q4 2025.